Long-term outcomes of late course accelerated hyper-fractionated radiotherapy for localized esophageal carcinoma in Mainland China: A meta-analysis

Diseases of the Esophagus

Volumn 24, Issue 7, 2011, Pages 495-501

  Zhang, Y W ^a   Chen, L ^a   Bai, Y ^a   Zheng, X ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Accelerated hyper fractionation; Esophageal carcinoma; Meta analysis; Radiotherapy

Indexed keywords

ARTICLE; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHINA; CONVENTIONAL FRACTIONATED RADIOTHERAPY; ESOPHAGUS CARCINOMA; HUMAN; INTERMETHOD COMPARISON; LATE COURSE ACCELERATED HYPERFRACTIONATED RADIOTHERAPY; MEDICAL RESEARCH; META ANALYSIS; PRIORITY JOURNAL; PUBLISHING; RADIATION DOSE FRACTIONATION; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

CARCINOMA, SQUAMOUS CELL; CHINA; DOSE FRACTIONATION; ESOPHAGEAL NEOPLASMS; HUMANS; TIME FACTORS; TREATMENT OUTCOME;

EID: 80052921629     PISSN: 11208694     EISSN: 14422050     Source Type: Journal    
DOI: 10.1111/j.1442-2050.2010.01173.x     Document Type: Article

References (25)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun M J. Cancer statistics. CA Cancer J Clin 2008; 58: 71-96.
2. Beatty J D, DeBoer G, Rider W D. Carcinoma of the esophagus: pretreatment assessment, correlation of radiation treatment parameters with survival, and identification and management of radiation treatment failure. Cancer 1979; 43: 2254-67.
3. Lambert R, Hainaut P. The multidisciplinary management of gastrointestinal cancer. Epidemiology of oesophagogastric cancer. Best Pract Res Clin Gastroenterol 2007; 21: 921-45.
4. Mariette C, Piessen G, Triboulet J P. Therapeutic strategies in oesophageal carcinoma: role of surgery and other modalities. Lancet Oncol 2007; 8: 545-53.
5. Withers H R, Tayl J M, Maciejewski B. The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncol 1988; 27: 131-46.
6. Kwong D L, Sham J S, Chua D T, Choy D T, Au G K, Wu P M. The effect of interruptions and prolonged treatment time in radiotherapy for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 1997; 39: 703-10.
7. Zhang H Y, Spechler S J, Souza R F. Esophageal adenocarcinoma arising in Barrett esophagus. Cancer Lett 2009; 275: 170-77.
8. He X Y, Liu T F, He S Q, Huan S L, Pan Z Q. Late course accelerated hyperfractionated radiotherapy of nasopharyngeal carcinoma (LCAF). Radiother Oncol 2007; 85: 29-35.
9. Zhao K L, Shi X H, Jiang G L, Yao W Q, Guo X M, Wu G D, Zhu L X. Late-course accelerated hyperfractionated radiotherapy for localized esophageal carcinoma. Int J Radiat Oncol Biol Phys 2004; 60: 123-9.
10. Wang Y, Shi X H, He S Q etal. Comparison between continuous accelerated hyper-fractionated and late-course accelerated hyper-fractionated radiotherapy for esophageal carcinoma. Int J Radiat Oncol Biol Phys 2002; 54: 131-6.
11. Qiao X Y, Zhou D A, Gao X S, Ma G X, Wang J. Comparison between conventional fractionation, late-course accelerated hyperfractionation and external beam combined with intracavitary radiation in the treatment of locally moderate and advanced esophageal carcinoma. Chin J Radiat Oncol 2004; 13: 261-4.
12. Ren B Z, Han L, Zhu P J, Shan C P, Kong F H. Late-course accelerated hyper-fractionated three-dimensional conformal radiotherapy for esophageal carcinoma with long-term result and prognostic analysis. Chin J Radiat Oncol 2006; 15: 93-6.
13. Shi X H, Yao W Q, Liu T F. Late course accelerated fractionation in radiotherapy of esophageal carcinoma. Radiother Oncol 1999; 51: 21-6.
14. Shi X H, Wu G D, Liu X W, Ma X J. Long term results of late course accelerated fractionation radiotherapy for esophageal carcinoma. Chin J Radiat Oncol 1997; 6: 12-15.
15. Han C, Yang X R, Gao X S, Zhou D A, Wang J. Late course accelerated hyper-fractionated radiotherapy for esophageal carcinoma. Chin J Radiat Oncol 1999; 8: 192.
16. Chen Y H. Result of late-course accelerated hyper-fractionated radiotherapy for esophageal carcinoma. Anhui Med J 2005; 2: 369-71.
17. Wang X H, Li J X, Gao K. Treatment of esophageal carcinoma by late-course accelerated hyperfractionation radiotherapy. J Med Forum 2006; 27: 24-5.
18. Bao Z L, Wei J, Xiang F, Ding R P. Curative effect of late course accelerated hyperfractionation radiotherapy for esophageal carcinoma. J Appl Gen Pract 2006; 4: 398-9.
19. Zhou X F, Xu X Y, Gu K, Zhou J. Cinical study of late course accelerated radiation in esophagus carcinoma. Chin J Clin Oncol 2002; 7: 119-20.
20. Jiang L H, Lei S B, Yu Y Q. Long term results of late course accelerated hyperfractionation radiotherapy for middle esophageal carcinoma. J Oncol 2002; 15: 448-9.
21. Hou E C, Lian Z P. Clinical study of carmofur combined with late course accelerated radiation in esophagus carcinoma. Cancer Res Prev Treat 2004; 31: 571-3.
22. Struikmans H, Kal H B, Hordijk G J, van der Tweel I. Proliferative capacity in head and neck cancer. Head Neck 2001; 23: 484-91.
23. Peters L J, Ang K K, Thames H D Jr. Accelerated fractionation in the radiation treatment of head and neck cancer. A critical comparison of different strategies. Acta Oncol 1988; 27: 185-94.
24. Suit H D, Howes, A F, Hunter, N. Dependance of response of a C3H mammary carcinoma to fractionated irradiation on fraction number and intertreatment interval. Radiat Res 1977; 72: 440-48.
25. Wong R K, Malthaner R. WITHDRAWN. Combined chemotherapy and radiotherapy (without surgery) compared with radiotherapy alone in localized carcinoma of the esophagus. Cochrane Database Syst Rev 2010; (1): CD002092.